Tess V. Dupre

432 citations
13 papers · 322 indexed · h-index 10
Topics
Chemotherapy-induced organ toxicity mitigation (7 papers)Acute Lymphoblastic Leukemia research (3 papers)Biomedical Research and Pathophysiology (3 papers)
Partner nations
United States

In The Last Decade

Tess V. Dupre

12 papers receiving 316 citations

Peers

Tess V. Dupre
Comparison fields: 5 of 72
  • Molecular Biology 141
  • Pathology and Forensic Medicine 129
  • Nephrology 85
  • Pediatrics, Perinatology and Child Health 34
  • Oncology 33
Replace Claus D. Schuh with:
Claus D. Schuh Switzerland
Jelle Vriend Netherlands
Asako Hayashi Japan
Xiaojie Wang China
Anthony W. Norman United States
Kate Witkowska Canada
Vidya S. Farook United States
Charles McKay United States
Tess V. Dupre relative to Claus D. Schuh Switzerland Claus D. Schuh's profile →
Citations per field
00.5×3.3×
Claus D. Schuh · 1×
Citations per year

Countries citing papers authored by Tess V. Dupre

Since Specialization
Citations

This map shows the geographic impact of Tess V. Dupre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tess V. Dupre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tess V. Dupre more than expected).

Fields of papers citing papers by Tess V. Dupre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tess V. Dupre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tess V. Dupre. The network helps show where Tess V. Dupre may publish in the future.

Co-authorship network of co-authors of Tess V. Dupre

This figure shows the co-authorship network connecting the top 25 collaborators of Tess V. Dupre. A scholar is included among the top collaborators of Tess V. Dupre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tess V. Dupre. Tess V. Dupre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 11
2 8
3 25
4 29
5 6
6 14
7 13
8 41
9 48
10 0
11 93
12 25
13 9

About Tess V. Dupre

Tess V. Dupre is a scholar working on Pathology and Forensic Medicine, Nephrology and Hematology, having authored 13 papers that have together received 322 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (7 papers), Acute Lymphoblastic Leukemia research (3 papers) and Biomedical Research and Pathophysiology (3 papers). The work is most often cited by research in Nephrology (85 citations), Pathology and Forensic Medicine (129 citations) and Clinical Biochemistry (21 citations). Tess V. Dupre has collaborated with scholars based in United States. Frequent co-authors include Leah J. Siskind, Levi J. Beverly, Parag P. Shah, Judit Megyesi, Cierra N. Sharp, Mark A. Doll, Deanna Siow, Gavin E. Arteel, Rick G. Schnellmann and Rick G. Schnellmann. Their work appears in journals such as The FASEB Journal, American Journal Of Pathology and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026